5
Participants
Start Date
November 30, 2009
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
clevidipine.
Clevidipine administered per IV infusion, starting dose of 2 mg/h (4 mL/hr) for 3 minutes \& titrated to the desired BP lowering effect to SBP goal of \< 120 mmHg, max infusion rate may not exceed 32 mg/h (64 mL/hr).
The Methodist Hospital, Houston
Collaborators (1)
The Medicines Company
INDUSTRY
The Methodist Hospital Research Institute
OTHER
Asma Zainab, M.D.
OTHER